Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,116 across all filing types
Latest filing 2024-01-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
关于《总部项目合作协议》及其补充协议的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress of a cooperation agreement related to the company's headquarters project, including the handover of retained properties. It details the signing of agreements, the status of property transfer, and the impact on the company. There are no financial statements, earnings data, or detailed financial analysis. The document is a formal announcement of a corporate development related to property and project cooperation, not a financial report or management discussion. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is also not a regulatory certification or insider dealing report. The content is best classified as a Regulatory Filing (RNS) because it is a general corporate announcement about project progress and property handover, which does not fit other specific categories.
2024-01-29 Chinese
2023年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2023 annual earnings forecast (业绩预告) for the full fiscal year 2023 (January 1 to December 31, 2023). It provides preliminary estimated net profit figures, explanations of changes, and risk warnings. It explicitly states that the forecast has not been audited and is a preliminary estimate, with detailed results to be disclosed in the full 2023 annual report. The document is short (1123 characters) and serves as an earnings preview rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. FY 2023
2024-01-26 Chinese
关于子公司获得化学原料药上市申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its subsidiary receiving approval from a regulatory authority (国家药品监督管理局) for a chemical raw material drug listing application. It contains no financial data, no detailed report, and is relatively short (740 characters). It is a regulatory announcement about an approval notice, not a financial report or detailed filing. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2023-12-13 Chinese
关于子公司获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1125 characters) from a listed company about its subsidiary receiving a government subsidy. It details the amount, reason, accounting treatment, and expected impact on profit. There are no financial statements or comprehensive financial data presented. The document is an official announcement of a specific event affecting the company, not a full financial report or earnings release. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a regulatory certification or officer attestation. The content is a regulatory announcement about a government subsidy received, which is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2023-12-12 Chinese
关于子公司获得阿哌沙班片药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (805 characters) from a company about its subsidiary obtaining a drug registration certificate from a national regulatory authority. It contains no financial data, no mention of financial results, no management discussion, no voting results, no capital changes, or other financial or governance information. It is an official announcement of a regulatory approval related to the company's product, not a financial report or detailed management report. The document is an announcement of a regulatory event related to the company, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-12-08 Chinese
关于持股5%以上股东部分股份质押延期的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the extension of a pledge on shares held by a shareholder owning more than 5% of the company's stock. It details the number of shares pledged, the extension period, and reassures investors about the absence of risks related to freezing or forced transfer of shares. The document is short (1376 characters) and focuses on a specific shareholder's share pledge extension, which is a capital-related update but not a full financial report or earnings release. It does not contain financial statements or management discussion. This fits the category of Capital/Financing Update (CAP), as it relates to changes in the company's capital structure through share pledging.
2023-12-08 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.